Could the largest market for the new schizophrenia drug xanomeline and trospium chloride (Cobenfy) be in Alzheimer's disease ...

Seasonal affective disorder (SAD) is a type of recurrent depressive periods that occur during the same season each year. SAD ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

California gastroenterologist Dr. Saurabh Sethi has called out three popular drinks that increase the risk of Alzheimer’s.

But more work remains. As a new member of Congress, Sen. Dave McCormick can play an important role in building on this ...

Late-onset Alzheimer's disease is a debilitating, progressive neurodegenerative disease that affects about 7 million ...

People who care for patients with Alzheimer's or other dementia must be alert when winter weather turns dangerous, advises ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Alzheimer's disease is likely caused by stalled protein processing in the brain, according to a new study.

The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...